Dipeptidyl peptidase

Results: 124



#Item
31DIABETES MANAGEMENT IN PRACTICE Nneka Agbasi Diabetes Specialist Nurse - ECS

DIABETES MANAGEMENT IN PRACTICE Nneka Agbasi Diabetes Specialist Nurse - ECS

Add to Reading List

Source URL: www.diabetes.org.uk

Language: English - Date: 2014-11-13 04:07:38
32Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2011 to year end: Jun[removed]Section 85 Only  Year ending Jun 2011 Rank Drug  Year ending Jun 2012

Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2011 to year end: Jun[removed]Section 85 Only Year ending Jun 2011 Rank Drug Year ending Jun 2012

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-01-19 18:01:25
33Vildagliptin for type 2 diabetes: No suitable data for combination with sulfonylurea

Vildagliptin for type 2 diabetes: No suitable data for combination with sulfonylurea

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-04-17 09:26:31
34SMC  briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
35Minutes of the SMC Meeting

Minutes of the SMC Meeting

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
36SMC  briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
37Endocrine system / Dipeptidyl peptidase-4 inhibitors / Diabetes / Peptide hormones / Eli Lilly and Company / Anti-diabetic medication / Exenatide / Metformin / Pioglitazone / Chemistry / Organic chemistry / Anti-diabetic drugs

Review of Diabetes Management Terms of Reference 3 Final Report May 2014 Newcastle Evaluation Group (NEG) Discipline of Clinical Pharmacology

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2014-10-09 02:50:09
38Endocrine system / Diabetes / Dipeptidyl peptidase-4 inhibitors / Amides / Eli Lilly and Company / Anti-diabetic medication / Metformin / Vildagliptin / Exenatide / Chemistry / Organic chemistry / Anti-diabetic drugs

DOCX Document

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2014-10-09 02:50:09
39Submission to the PBAC Post Market Review of Products Used in the Management of Diabetes: Drug Utilisation and Listing Review Boehringer Ingelheim welcomes the opportunity to comment on the Post-Market Review of Products

Submission to the PBAC Post Market Review of Products Used in the Management of Diabetes: Drug Utilisation and Listing Review Boehringer Ingelheim welcomes the opportunity to comment on the Post-Market Review of Products

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 22:38:57
40Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2011 to year end: Jun[removed]Section 85 Only  Year ending Jun 2011 Rank Drug  Year ending Jun 2012

Table 8(a):Significant drugs (incl Drs bag)-sorted by highest change to Government cost, year end: Jun 2011 to year end: Jun[removed]Section 85 Only Year ending Jun 2011 Rank Drug Year ending Jun 2012

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-01-19 18:01:25